- Home
- XTNT vs ANIX Comparison
XTNT vs ANIX Comparison
Compare XTNT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ANIX
- Stock Information
- Founded
- XTNT N/A
- ANIX 1982
- Country
- XTNT United States
- ANIX United States
- Employees
- XTNT N/A
- ANIX N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- ANIX Health Care
- Exchange
- XTNT Nasdaq
- ANIX Nasdaq
- Market Cap
- XTNT 82.1M
- ANIX 95.7M
- IPO Year
- XTNT N/A
- ANIX 1987
- Fundamental
- Price
- XTNT $0.62
- ANIX $2.98
- Analyst Decision
- XTNT
- ANIX Strong Buy
- Analyst Count
- XTNT 0
- ANIX 3
- Target Price
- XTNT N/A
- ANIX $9.00
- AVG Volume (30 Days)
- XTNT 91.3K
- ANIX 57.4K
- Earning Date
- XTNT 08-12-2025
- ANIX 08-27-2025
- Dividend Yield
- XTNT N/A
- ANIX N/A
- EPS Growth
- XTNT N/A
- ANIX N/A
- EPS
- XTNT N/A
- ANIX N/A
- Revenue
- XTNT $127,766,000.00
- ANIX N/A
- Revenue This Year
- XTNT $13.03
- ANIX N/A
- Revenue Next Year
- XTNT N/A
- ANIX N/A
- P/E Ratio
- XTNT N/A
- ANIX N/A
- Revenue Growth
- XTNT 15.16
- ANIX N/A
- 52 Week Low
- XTNT $0.33
- ANIX $2.07
- 52 Week High
- XTNT $0.78
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- XTNT 49.51
- ANIX 46.10
- Support Level
- XTNT $0.59
- ANIX $2.93
- Resistance Level
- XTNT $0.65
- ANIX $3.20
- Average True Range (ATR)
- XTNT 0.04
- ANIX 0.11
- MACD
- XTNT -0.00
- ANIX 0.01
- Stochastic Oscillator
- XTNT 47.67
- ANIX 21.43
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.